Effect of Yogurt on Minimal Hepatic Encephalopathy
NCT00312078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2007-11-01
Summary
The purpose of this study is to determine whether a special yogurt can improve performance on certain tests of intelligence and decrease liver inflammation in patients with cirrhosis.
Conditions
- Cirrhosis
- Minimal Hepatic Encephalopathy
Interventions
- DIETARY_SUPPLEMENT
-
Yogurt Supplementation
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Jasmohan S Bajaj, MD · Medical College of Wisconsin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 24 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Completion
- 2007-04-30
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis.
NCT02265328 ·Status: COMPLETED ·Phase: PHASE2
-
S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE
NCT01446523 ·Status: COMPLETED ·Phase: NA
-
Digestion of Biopolymer Based Lipid Emulsions
NCT02865486 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
NCT01002261 ·Status: COMPLETED
-
Effect of Plasma Ceramides on Peripheral Vascular Function
NCT05107869 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
NCT00004796 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
NCT02690792 ·Status: COMPLETED ·Phase: NA
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
NCT01008293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
NCT01466894 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06133101 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
NCT02048969 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease
NCT01088087 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 ·Status: COMPLETED ·Phase: NA
-
Magnesium in Liver Cirrhosis
NCT01894867 ·Status: UNKNOWN ·Phase: PHASE4
-
Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy
NCT02022137 ·Status: COMPLETED ·Phase: NA
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212186 ·Status: COMPLETED ·Phase: NA
-
Alleviation Of Metabolic Endotoxemia In Adults With Metabolic Syndrome With Milk Fat Globule Membrane
NCT03860584 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
NCT06072521 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212212 ·Status: TERMINATED ·Phase: NA
-
Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study
NCT02520817 ·Status: COMPLETED
-
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis
NCT03855956 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
NCT01968382 ·Status: COMPLETED ·Phase: PHASE2